Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition

Despite recent progress in the treatment, the outcome of adult acute T-cell lymphoblastic leukemia (T-ALL) is poor. Development of novel approach to combat this disease is urgently required. Vorinostat, a pan-histone deacetylase (HDAC) inhibitor, exerts promising anticancer activity in a variety of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Jing, Bo, Jin, Jin, Xiang, Rufang, Liu, Meng, Yang, Li, Tong, Yin, Xiao, Xinhua, Lei, Hu, Liu, Wei, Xu, Hanzhang, Deng, Jiong, Zhou, Li, Wu, Yingli
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5964102/
https://ncbi.nlm.nih.gov/pubmed/29789603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0679-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados